MARKET WIRE NEWS

NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition

Source: SeekingAlpha

2026-04-21 19:31:26 ET

More on NEXGEL

Read the full article on Seeking Alpha

For further details see:

NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition
NexGel Inc

NASDAQ: NXGL

NXGL Trading

14.42% G/L:

$0.595 Last:

377,697 Volume:

$0.53 Open:

VWAV Ad 300

NXGL Latest News

NXGL Stock Data

$10,748,936
6,469,719
5.78%
9
N/A
Medical Equipment & Supplies
Healthcare
US
Langhorne

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App